BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11102894)

  • 1. Altered expression of HLA class I antigens in breast cancer: association with prognosis.
    Gudmundsdóttir I; Gunnlaugur Jónasson J; Sigurdsson H; Olafsdóttir K; Tryggvadóttir L; Ogmundsdóttir HM
    Int J Cancer; 2000 Nov; 89(6):500-5. PubMed ID: 11102894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
    Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
    Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
    Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F
    Eur J Immunogenet; 1995 Aug; 22(4):299-310. PubMed ID: 7495782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
    Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
    J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
    Bijen CB; Bantema-Joppe EJ; de Jong RA; Leffers N; Mourits MJ; Eggink HF; van der Zee AG; Hollema H; de Bock GH; Nijman HW
    Int J Cancer; 2010 Mar; 126(6):1417-27. PubMed ID: 19728333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas.
    Pupa SM; Bufalino R; Invernizzi AM; Andreola S; Rilke F; Lombardi L; Colnaghi MI; Ménard S
    J Clin Oncol; 1996 Jan; 14(1):85-94. PubMed ID: 8558226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
    He X; Dong DD; Yie SM; Yang H; Cao M; Ye SR; Li K; Liu J; Chen J
    Ann Surg Oncol; 2010 May; 17(5):1459-69. PubMed ID: 20052552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MHC class I and class II antigens in primary breast carcinomas and synchronous nodal metastases.
    Maiorana A; Cesinaro AM; Fano RA; Collina G
    Clin Exp Metastasis; 1995 Jan; 13(1):43-8. PubMed ID: 7820955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
    Wintzer HO; Benzing M; von Kleist S
    Br J Cancer; 1990 Aug; 62(2):289-95. PubMed ID: 2201398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
    Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
    Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.
    Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A
    Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma.
    Lucin K; Iternicka Z; Jonjić N
    Pathol Res Pract; 1994 Dec; 190(12):1134-40. PubMed ID: 7792204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical analysis of HLA class I subunits expression in breast cancer tissues.
    Pistillo MP; Nicolò G; Salvi S; Capanni P; Perdelli L; Pasciucco G; Ferrara GB
    Hum Immunol; 2000 Apr; 61(4):397-407. PubMed ID: 10715517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved Axin expression is associated with an aggressive phenotype in invasive breast carcinomas.
    Irini T; Paraskevi A; Ioanna G; Christos P; Lydia N
    APMIS; 2013 Sep; 121(9):797-805. PubMed ID: 23278310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.
    de Kruijf EM; Sajet A; van Nes JG; Natanov R; Putter H; Smit VT; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
    J Immunol; 2010 Dec; 185(12):7452-9. PubMed ID: 21057081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
    Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D
    Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer.
    Kaklamanis L; Leek R; Koukourakis M; Gatter KC; Harris AL
    Cancer Res; 1995 Nov; 55(22):5191-4. PubMed ID: 7585572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
    Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.